Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000604523 | SCV000725664 | likely benign | not specified | 2017-12-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000732671 | SCV000860648 | uncertain significance | not provided | 2018-04-17 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001055033 | SCV001219397 | likely benign | Developmental and epileptic encephalopathy, 9 | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002532792 | SCV003538668 | likely benign | Inborn genetic diseases | 2022-12-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |